CLOs on the Move

AGENIXS

www.agenixs.com

 
Agenixs creates change in the world by elevating people to healthier, longer, and more fulfilling lives, empowering each on their own journey of changing the world.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.agenixs.com
  • 100 E Walton Street 2nd Floor
    Chicago, IL USA 60611
  • Phone: 312.981.4020

Executives

Name Title Contact Details

Similar Companies

Instem LSS

Instem LSS is a Conshohocken, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Health Communication Systems

Health Communication Systems is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cerebrio

Cerebrio is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nue Life Health

https://t.co/QHy4u1rf0W is a next-gen mental wellness company that believes in the power of psychedelics to catalyze lasting change.

Synthetic Biologics

Synthetic Biologics, Inc. trades on the NYSE MKT, LLC under the symbol "SYN". The Company`s principal executive offices are located in Rockville, MD, and the finance and administrative office is located in Ann Arbor, MI. Synthetic Biologics, Inc. is a microbiome-focused, clinical-stage company developing therapeutics to protect the microbiome while targeting pathogen-specific diseases. The Company`s lead candidates in Phase 2 development include SYN-004 which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection and antibiotic-associated diarrhea (AAD), and SYN-010 which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat the underlying cause of irritable bowel syndrome with constipation (IBS-C). In addition, the Company is developing a monoclonal antibody combination for the treatment of Pertussis, and a Phase 2 oral estriol drug for the treatment of relapsing-remitting multiple sclerosis (MS) and cognitive dysfunction in MS.